Thursday, October 17 7:30–8:45am
P.A.C.T.: Practical Approaches to Comprehensive Treatment of Pain (Part 1)
Thursday, October 17 9–11:15am
P.A.C.T.: Practical Approaches to Comprehensive Treatment of Pain (Part 2)
Wednesday, October 16 10–11am
Alzheimer Disease in Primary Care: Early Identification and New Anti-Amyloid Treatment Options
Wednesday, October 16 10–11am
Alzheimer Disease in Primary Care: Early Identification and New Anti-Amyloid Treatment Options
Thursday, October 17 7:30–8:45am
P.A.C.T.: Practical Approaches to Comprehensive Treatment of Pain (Part 1)
Thursday, October 17 9–11:15am
P.A.C.T.: Practical Approaches to Comprehensive Treatment of Pain (Part 2)
Thursday, October 17 7:30–8:45am
P.A.C.T.: Practical Approaches to Comprehensive Treatment of Pain (Part 1)
Thursday, October 17 9–11:15am
P.A.C.T.: Practical Approaches to Comprehensive Treatment of Pain (Part 2)
Wednesday, October 16 8–9am
Two Sides of the Same Coin: A Dual-Focused Approach for Diabetes and Weight Management
Thursday, October 17 11:45am–12:45pm
Creating Health Equity in Pain Management: Strategies for Bridging the Gap
Wednesday, October 16 2:15–3pm
Curbside Consults: Top Questions from PCPs on Kidney Disease
Wednesday, October 16 4–5:30pm
Taking the Dialogue to the Next Level: Facilitating Open Communication About Obesity
Wednesday, October 16 8–9am
Two Sides of the Same Coin: A Dual-Focused Approach for Diabetes and Weight Management
Wednesday, October 16 11am–12pm
Gut Check: IBS/Constipation, CRC Screening, and Acid-Peptic Disorders
Wednesday, October 16 7:30–8am
Test Your Knowledge: Labs & Imaging, Pulmonology, Rheumatology and More!
Wednesday, October 16 1–2pm
Wednesday, October 16 4–5:30pm
Taking the Dialogue to the Next Level: Facilitating Open Communication About Obesity
Wednesday, October 16 3–3:45pm
Aging Minds, Unique Challenges: Addressing Psychiatric Disorders in the Elderly Population
Disclosures
The following financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute. Relevant relationships will be disclosed at the start of each presentation.
Financial Disclosures
- Charles E. Argoff, MD, FABPM
- AbbVie, Researcher; AbbVie, Lilly, Scilex, Lundbeck, Averitas Pharma, Teva, Impel, Kowa Pharmaceuticals, Nevro, Speaker; Collegium, Scilex, Vertex, Xgene Pharma, Tris, PainScripts, Nevro, Consultant; Lundbeck and Teva, Other; Pfizer and Trevana, Stock Holder (publicly traded company)
- Katherine Carroll, MD
- No relevant financial relationships disclosed.
- Amy Clouse, MD, FAAFP
- Astellas Pharma, Advisor; Astellas Pharma, Speaker
- Anelyssa D'Abreu, MD, MPH, PhD
- No relevant financial relationships disclosed.
- Oscar A. de Leon-Casasola, MD
- Merck Pharmaceuticals, Vertex Pharmaceuticals., Consultant
- Katherine E. Galluzzi, DO, CMD, FACOFP
- No relevant financial relationships disclosed.
- Jennifer B. Green, MD
- AstraZeneca, Boehringer Ingelheim, Lilly, and Novo Nordisk, Consultant; Boehringer Ingelheim, Researcher
- Gregory L. Hall, MD
- No relevant financial relationships disclosed.
- Stephen N. Henry, DO, MS
- No relevant financial relationships disclosed.
- Melanie Hoenig, MD
- No relevant financial relationships disclosed.
- Joynita R. Nicholson, DO, DABOM, FOMA
- No relevant financial relationships disclosed.
- Vani Potluri, MD
- No relevant financial relationships disclosed.
- Philip Schoenfeld, MD, MSEd, MSc
- AbbVie Pharmaceuticals, Advisor; Ironwood Pharmaceuticals, Pharmaceuticals, Exact Sciences, Phathom Pharmaceuticals, and Ardelyx Pharmaceuticals, Speaker; Ironwood Pharmaceuticals, Phathom Pharmaceuticals, Salix Pharmaceuticals, and Ardelyx Pharmaceuticals, Advisor
- Charles Vega, MD, FAAFP
- GlaxoSmithKline, Boehringer Ingelheim, and Exact Sciences, Consultant
- Shirah Vollmer, MD
- No relevant financial relationships disclosed.
Other Disclosures
Pamela Kushner, MD, FAAFP (Moderator, Reviewer): Speaker for Astellas, Bayer, and Corcept; Speaker & Advisor for AstraZeneca, GlaxoSmithKline, Janssen, Novo Nordisk, Lilly/BI, and Phathom; Speaker & Consultant for Haleon; Advisor for Abbott, Bausch/SALIX, Intuity, and Pfizer; Consultant for Abbott, AstraZeneca, Bayer, Boehringer Ingelheim, GlaxoSmithKline, and Lilly.
All other non-faculty contributors involved in the moderating, planning, development, editing and review of the content have disclosed no relevant financial relationships.